Sodaif Darvish Moghaddam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sodaif Darvish Moghaddam has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Javad Zahedi
Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
2 shared publications Ahmad Ebrahimi
Private Clinical Laboratory Specialist, Kerman University of Medical Sciences, Kerman, Iran
1 shared publicationAli Asadipour
Department of Medicinal Chemistry, Pharmaceutical Research Center, School of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication- Alireza Nasiri
Environmental Health Engineering Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication Fariba Sharififar
Herbal and Traditional Medicines Research Center, Faculty of Pharmacy, Kerman University of Medical Science, Kerman, Iran
1 shared publicationFarzane Ebrahimi Meimand
Department of Cardiology, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication
Latest Publications
- Open Access
- 12 August 2017
- Published by Springer Nature in Applied Water Science
- Vol. 7 (8) , 4437-4447
Performance evaluation of household water treatment systems used in Kerman for removal of cations and anions from drinking water
- 12 August 2017
- Published by Springer Nature in Applied Water Science
- Vol. 7 (8) , 4437-4447
Open AccessPerformance evaluation of household water treatment systems used in Kerman for removal of cations and anions from drinking water
- Open Access
- 1 May 2015
- Vol. 40 (3) , 214-218
Serum Selenium Level in Patients with Gastric Non-Cardia Cancer and Functional Dyspepsia
Background: Gastric cancer (GC) is the most common gastrointestinal cancer in Iran. Helicobacter pylori (H. pylori) accounts as one of the main risk factors for gastric non-cardia cancer (GNCC). It is suggested that high serum selenium level may have a protective role in GNCC. In this cross-sectional study, we determined the serum Se level and the status of H. pylori infection in two populations with GC and functional dyspepsia (FD). Methods: The enrolled patients were 85 (27 women, 58 men) with recent pathologically proven GNCC (adenocarcinoma) and 85 (34 women, 51 men) FD patients. Serum Se was measured by atomic absorption spectrophotometry. H. pylori IgG antibody was detected by quantitative enzyme immunoassay. Results: The mean age in the GNCC and FD patients were 62.85 +/- 14.6 and 58.9 +/- 14.7 years, respectively (P=0.08). The serum selenium levels were 111.6 +/- 27.7 and 129.9 +/- 32.1 mu g/L (mean +/- SD) in GNCC and FD patients, respectively (P < 0.001). The frequency of H. pylori infection was 49.4% (n=42) and 68.2% (n=58) in GNCC and FD patients (P=0.013). The crude and adjusted odds ratio (OR) between GNCC and the linear effect of serum selenium level were 0.98 and 0.982, respectively (P=0.002). This means that each unit increase in serum selenium level decreases the odds of cancer by 2%. Conclusion: Serum selenium level was significantly lower in GNCC cases. It suggests that lower serum selenium might have some association with the risk of GNCC. H. pylori infection does not play a significant impact on this association.
- 1 May 2015
- Vol. 40 (3) , 214-218
Open AccessSerum Selenium Level in Patients with Gastric Non-Cardia Cancer and Functional Dyspepsia
Background: Gastric cancer (GC) is the most common gastrointestinal cancer in Iran. Helicobacter pylori (H. pylori) accounts as one of the main risk factors for gastric non-cardia cancer (GNCC). It is suggested that high serum selenium level may have a protective role in GNCC. In this cross-sectional study, we determined the serum Se level and the status of H. pylori infection in two populations with GC and functional dyspepsia (FD). Methods: The enrolled patients were 85 (27 women, 58 men) with recent pathologically proven GNCC (adenocarcinoma) and 85 (34 women, 51 men) FD patients. Serum Se was measured by atomic absorption spectrophotometry. H. pylori IgG antibody was detected by quantitative enzyme immunoassay. Results: The mean age in the GNCC and FD patients were 62.85 +/- 14.6 and 58.9 +/- 14.7 years, respectively (P=0.08). The serum selenium levels were 111.6 +/- 27.7 and 129.9 +/- 32.1 mu g/L (mean +/- SD) in GNCC and FD patients, respectively (P < 0.001). The frequency of H. pylori infection was 49.4% (n=42) and 68.2% (n=58) in GNCC and FD patients (P=0.013). The crude and adjusted odds ratio (OR) between GNCC and the linear effect of serum selenium level were 0.98 and 0.982, respectively (P=0.002). This means that each unit increase in serum selenium level decreases the odds of cancer by 2%. Conclusion: Serum selenium level was significantly lower in GNCC cases. It suggests that lower serum selenium might have some association with the risk of GNCC. H. pylori infection does not play a significant impact on this association.
- Open Access
- 1 May 2012
- Published by Brieflands in Hepatitis Monthly
- Vol. 12 (5) , 339-343
Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran
Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran - Hepatitis Monthly - 2012 - Kowsar
- 1 May 2012
- Published by Brieflands in Hepatitis Monthly
- Vol. 12 (5) , 339-343
Open AccessSeroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran
Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran - Hepatitis Monthly - 2012 - Kowsar